Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0580
D

Failure to Notify Responsible Party of New Insulin Medication

Norwalk, California Survey Completed on 01-07-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to notify the responsible party (RP) when a resident was started on a new insulin medication, Lantus, resulting in a violation of the RP’s right to be informed and involved in treatment decisions. The resident’s face sheet showed admission with diagnoses including cerebral infarction, metabolic encephalopathy, and type 2 DM. The resident’s H&P dated 8/29/2025 documented that the resident did not have the capacity to understand and make decisions, and the MDS dated 8/14/2025 indicated severe cognitive impairment with the resident rarely or never able to understand and be understood by others. A physician’s order dated 12/8/2025 directed that the resident receive Lantus 16 units subcutaneously at bedtime for type 2 DM, to be held if blood sugar was less than 150. The MAR for 12/2025 showed that Lantus was administered at 9 p.m. from 12/8/2025 through 12/31/2025. During a telephone interview, the RP stated she learned from the resident’s insurance company that Lantus had been started, and she expressed anger that the facility had not informed her of the new medication, stating that the facility undermined her authority and right to contribute to the resident’s plan of care and that she felt distrustful toward the facility. In an interview, the DON stated that review of the medical record revealed no documentation that the RP was notified when Lantus was added and confirmed there was no record of any discussion with the RP regarding Lantus prior to its initiation. The facility’s P&P titled “Change in Resident’s Condition or Status,” dated 5/2022, required prompt notification of the resident, attending physician, and representative of changes in the resident’s medical/mental condition or status and stated that a nurse or healthcare provider would inform the resident of any changes in medical care or nursing treatments, regardless of the resident’s current condition.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙